Breckenridge Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRECKENRIDGE PHARM, and what generic and branded alternatives to BRECKENRIDGE PHARM drugs are available?
BRECKENRIDGE PHARM has five approved drugs.
There are three tentative approvals on BRECKENRIDGE PHARM drugs.
Summary for Breckenridge Pharm
US Patents: | 0 |
Tradenames: | 5 |
Ingredients: | 5 |
NDAs: | 5 |
Patent Litigation for Breckenridge Pharm: | See patent lawsuits for Breckenridge Pharm |
PTAB Cases with Breckenridge Pharm as petitioner: | See PTAB cases with Breckenridge Pharm as petitioner |
Drugs and US Patents for Breckenridge Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge Pharm | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 078069-003 | Jan 11, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Breckenridge Pharm | TERBINAFINE HYDROCHLORIDE | terbinafine hydrochloride | TABLET;ORAL | 077714-001 | Jun 4, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Breckenridge Pharm | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 077736-001 | May 26, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.